ReviewCurrent cancer drug targets2022

Netupitant-palonosetron (NEPA) for Preventing Chemotherapy-induced Nausea and Vomiting: From Clinical Trials to Daily Practice.

Matti Aapro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.